A
Acumen Pharmaceuticals (ABOS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Acumen Pharmaceuticals (ABOS)
Acumen Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel disease-modifying approach to target causes of Alzheimer's disease. Acumen Pharmaceuticals serves customers worldwide.
- USD1.78
- USD1.86
- USD1.75
- USD5.09
- -21.90%
- --
- 995.50k
- 344.00k
- 122M
- 1.72
- -39.90%
Stock News
yesterday
Google Leads Five Stocks Near Buy Points, Standing Tall In Tricky Market
Yahoo
yesterday
Netflix expected to broaden subscriber base after winning Women’s World Cup bid
MarketWatch
yesterday
4 Tech Titans Will Spend a Combined $300 Billion on Artificial Intelligence (AI) in 2025, According to 1 Wall Street Firm. This Stock Could Be the Biggest Winner.
Yahoo
yesterday
Walmart, GM, Nvidia, Robinhood: All had an award-winning 2024
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
